Search
for
Sort by
Research 91–120 of 1000+
- Evaluation of Serum Homocysteine Levels in Patients with Cutaneous-Oral Lichen Planus and Psoriasis Patients
- Should hair transplantation be performed in psoriasis?
- Calcitriol ointment in the treatment of facial, hairline and retroauricular chronic plaque psoriasis
- TNF-α Inhibitor-Induced Psoriasis and Psoriatic Alopecia in Adolescent with Ulcerative Colitis: Clinical Case
- Psoriatic Alopecia in a Patient with Systemic Lupus Erythematosus
- CD169+ Skin Macrophages Function as a Specialized Subpopulation in Promoting Psoriasis-like Skin Disease in Mice
- Nano-Transfersomes of Vitamin-E and Aloe-Vera for The Management of Psoriasis
- ANDROGRAPHOLIDE LOADED TOPICAL NANOCARRIERS FOR MANAGEMENT OF PSORIASIS: A SAFE AND EFFECTIVE APPROACH
- A Case of Steatocystoma Multiplex in a Psoriatic Patient during Treatment with Anti-IL-12/23
- Interleukin 17 Expression in Psoriatic Skin Lesions before and after Treatment with Platelet Rich Plasma (PrP)
- Evaluation of serum brain-derived neurotrophic factor to assess the association between psoriasis and depression
- Is Wnt5a overexpression sufficient for generating a psoriasis‐like phenotype in transgenic mice?
- Coexistence of psoriasis, and alopecia areata with trachyonychia in a pediatric patient with Turner Syndrome
- Psoriasis in the limelight: the remarkable career of an old skin disease
- A cross-sectional observational study showing sebaceous glands differences between psoriatic alopecia and alopecia areata
- Scarring Alopecia in Tumor Necrosis Factor-α Antagonists-Induced Scalp Psoriasis
- Psoriasiform skin reaction due to Brazilian keratin treatment
- Sodium valproate-aggravated psoriasiform eruption
- New Perspectives on Nutraceutical Insulin Sensitizing Agents in the Treatment of Psoriasis and Other Dermatological Diseases
- PLGA–Soya Lecithin Based Hybrid Nanocomposite for Targeted Topical Delivery of Resveratrol in Psoriasis Management
- 265 Modulation of disease-central cytokine pathways with TAK-279, a highly selective oral tyrosine kinase 2 (TYK2) inhibitor, defines clinical response in patients with psoriasis
- Psoriasis and Related Disorders
- P07 Pityriasis amiantacea: a unique presentation of psoriasis associated with tumour necrosis factor-α inhibitor therapy
- 43927 The Impact of Treatment with Guselkumab on Skin-related Quality of Life in Male and Female Patients with Moderate to Severe Psoriasis: Results from the VOYAGE 1 and 2 Trials
- Can Platelet-Rich Plasma Reduce the Burden of Inflammatory Skin Diseases Such as Psoriasis and Atopic Dermatitis?
- Compounded topical preparations in plaque psoriasis: Still a place for it in 2018?
- The Association of Diffuse Alopecia Areata and Psoriasis Vulgaris in a Young Child
- Association between Vitamin D Deficiency and Psoriasis: A Case-Control Study
- Plaque psoriasis
- Loss of epidermal Evi/Wls results in a phenotype resembling psoriasiform dermatitis